Lisa Renee Schultz, LMSW, CSW-I, CADC | |
975 Roberta Ln Ste 104, Sparks, NV 89431-6812 | |
(775) 525-1616 | |
Not Available |
Full Name | Lisa Renee Schultz |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 975 Roberta Ln Ste 104, Sparks, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043732571 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | 00634-C (Nevada) | Secondary |
1041C0700X | Social Worker - Clinical | IC-1964 (Nevada) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lisa Renee Schultz, LMSW, CSW-I, CADC 6125 Chimney Dr, Sun Valley, NV 89433-6810 Ph: (775) 378-7768 | Lisa Renee Schultz, LMSW, CSW-I, CADC 975 Roberta Ln Ste 104, Sparks, NV 89431-6812 Ph: (775) 525-1616 |
News Archive
A treatment derived from human embryonic stem cells improves mobility in rats with spinal cord injuries, providing the first physical evidence that the therapeutic use of these cells can help restore motor skills lost from acute spinal cord tissue damage.
Lead is a toxic metal, and its widespread use has led to significant environmental pollution and public health problems in many parts of the world.
Bone marrow contains hematopoetic stem cells, the precursors to every blood cell type. These cells spring into action following bone marrow transplants, bone marrow injury and during systemic infection, creating new blood cells, including immune cells, in a process known as hematopoiesis.
XenoPort announced today that new data from clinical trials of its product candidates arbaclofen placarbil and XP13512 (gabapentin enacarbil) will be presented at the 62nd Annual American Academy of Neurology meeting in Toronto, Ontario.
› Verified 8 days ago